Overview

  • Product name

    Cytarabine, Pyrimidine nucleoside analog
  • Description

    Pyrimidine nucleoside analog
  • Biological description

    Pyrimidine nucleoside analog able to inhibits DNA synthesis. Active specifically on the S phase of the cell cycle. Chemotherapeutic agent. Antiviral and immunosuppressant properties.
  • Purity

    > 99%
  • CAS Number

    147-94-4
  • Chemical structure

    Chemical Structure

Properties

References

This product has been referenced in:

  • Sharma P  et al. Synthesis of cytarabine lipid drug conjugate for treatment of meningeal leukemia: development, characterization and in vitro cell line studies. J Biomed Nanotechnol 8:928-37 (2012). Read more (PubMed: 23030001) »
  • Sampath D  et al. Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial. Blood 107:2517-24 (2006). Read more (PubMed: 16293603) »
  • Hamada A  et al. Clinical pharmacokinetics of cytarabine formulations. Clin Pharmacokinet 41:705-18 (2002). Read more (PubMed: 12162758) »
See 1 Publication for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab141924.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES, NOT FOR USE IN HUMANS"
For licensing inquiries, please contact partnerships@abcam.com

Sign up